PeptidePedia The community reference

Talk:Prescribing information

Discussion page·2 threads·no archives

This article is within the scope of the regulation working group.

This is the discussion page for the article Prescribing information. It is for improving the article: sources, wording, structure, scope and titles. It is not a general discussion forum about the subject, and it is not a place to ask for advice — see Project:Medical disclaimer.

Warnings versus contraindicationsResolved

These get conflated constantly and the conflation overstates restriction. The distinction is one sentence and worth it. — LabelLibby (talk) 09:45, 10 March 2026 (UTC)

Cross-linked to the contraindications article, which handles the incretin-specific detail. ✓ Done — ClinicCorrespondent (talk) 13:20, 10 March 2026 (UTC)

Resolved. This thread is closed. Reopening it is fine if new sources appear; please add a new subsection rather than editing the closed discussion.

No label for research materialDone

The final table row is the one this wiki most needs: clinical information about an approved product is not information about a research chemical. — DisclosureDido (talk) 10:15, 1 June 2026 (UTC)

Stated plainly rather than implied. ✓ Done — ScopeSeverin (talk) 13:50, 1 June 2026 (UTC)

Done. This thread is closed. Reopening it is fine if new sources appear; please add a new subsection rather than editing the closed discussion.
This page was last edited on 1 June 2026, by ScopeSeverin. Text is available under the PeptidePedia Wiki Content Licence (PPCL-BY-SA 4.0).